Short-course vunakizumab associated with rapid improvement of acute flares in paediatric generalised pustular psoriasis: a three-patient case series. [PDF]
Huang J +5 more
europepmc +1 more source
Comparison of the Effects and Safety of Planned Limited-Time Withdrawal Versus Continuous Maintenance of Interleukin Inhibitors in Patients with Psoriasis: A Systematic Review and Network Meta-Analysis. [PDF]
de Sena RR +5 more
europepmc +1 more source
Interleukin-17A inhibitors for guttate psoriasis treatment: A retrospective cohort study. [PDF]
Man XY, Zhao GY, Ye LR.
europepmc +1 more source
Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort. [PDF]
Xuan Z +10 more
europepmc +1 more source
The Evaluation of the Clinical Effectiveness and Safety of Biologic Therapies in Psoriasis-Real-World Evidence up to 64 Weeks of Therapy. [PDF]
Lemiesz P +3 more
europepmc +1 more source
Hidradenitis suppurativa and psoriasis: shared immunological links with metabolic-associated steatotic liver disease. [PDF]
Chng WQ +5 more
europepmc +1 more source
Prostate adenocarcinoma in HIV-associated type 6 pityriasis rubra pilaris: A case report. [PDF]
Skipper A +3 more
europepmc +1 more source
Kaposi Sarcoma Under Immunosuppression. [PDF]
Thiele T, Behrens GMN.
europepmc +1 more source
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre study. [PDF]
Paci V +19 more
europepmc +1 more source
FIB-3 index and serum CK-18F level for monitoring suspected progression to metabolic dysfunction-associated steatohepatitis in biologic-controlled psoriasis: Two case reports and literature review on noninvasive markers. [PDF]
Suzuki C +4 more
europepmc +1 more source

